Molecular Characterization and Antimicrobial Resistance Pattern of Escherichia coli Recovered from Wastewater Treatment Plants in Eastern Cape South Africa

Abstract

Wastewater treatment plants (WWTPs) are designed to eliminate organic matter and pathogens but most WWTPs discharges antimicrobial resistance pathogens into aquatic milieu. The study aimed to examine the antibiotics resistant patterns and the presence of some resistance genes among E. coli isolates from WWTPs effluents. Water were collected from WWTPs final effluents, filtered through nitrocellulose membrane and the filter papers were placed on chromogenic agar plates, incubated for 24 h at 37 °C. Presumptive E. coli isolates (173) were obtained from the culture method. From the presumptive E. coli isolates screened by polymerase chain reaction (PCR), 111 isolates were positive and the positive isolates were further screened for six diarrheagenic E. coli pathotypes (EPEC, ETEC, EHEC, DAEC, EIEC, and EAEC) and from the pathotypes screened, nine isolates harboured daaE gene. The phenotypic susceptibility patterns of the 111 isolates to 12 antibiotics were determined by Kirby-Bauer disk diffusion technique. All the isolates were resistant to erythromycin and clindamycin. From the resistance genes screened, 31 isolates harboured mcr-1 gene and nine isolates harboured ermA gene. The study reveals that water samples recovered from the final effluents of WWTPs may likely be one of the major sources of antibiotic-resistant in Escherichia coli.

Keywords: Escherichia coli; WWTPs; diarrheagenic; susceptibility.

Figure 1

Gel image for the molecular confirmation of E. coli isolates using the uidA (147bp) gene. Lane M: 100bp DNA ladder, Lane 1: Negative control, Lane 2–12 samples.

Figure 2

Antimicrobial susceptibility patterns of E. coli isolated from wastewater treatment plants (WWTPs) in the Eastern Cape South Africa. Clindamycin (CD), Amoxicillin (A), Colistin-sulphate (CO), Erythromycin (E), Doxycyline (DXT), Cefuroxime (CXM), Meropenem (MEM), Gentamicin (GM), Ofloxacin (OFX), Trimethgoprim (TM), Sulphamethaxole (SMX), and Ciprofloxacin (CIP).